NASOVAX Trademark

Trademark Overview


On Sunday, March 22, 2020, a trademark application was filed for NASOVAX with the United States Patent and Trademark Office. The USPTO has given the NASOVAX trademark a serial number of 88843367. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 4, 2023. This trademark is owned by Altimmune, Inc.. The NASOVAX trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines
nasovax

General Information


Serial Number88843367
Word MarkNASOVAX
Filing DateSunday, March 22, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 4, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 9, 2021

Trademark Statements


Goods and ServicesVaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 25, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAltimmune, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Party NameAltimmune, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events


Event DateEvent Description
Tuesday, September 5, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 4, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, January 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 25, 2023SOU EXTENSION 3 GRANTED
Wednesday, January 25, 2023SOU EXTENSION 3 FILED
Wednesday, January 25, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 27, 2022SOU EXTENSION 2 GRANTED
Wednesday, July 27, 2022SOU EXTENSION 2 FILED
Wednesday, July 27, 2022SOU TEAS EXTENSION RECEIVED
Friday, January 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 26, 2022SOU EXTENSION 1 GRANTED
Wednesday, January 26, 2022SOU EXTENSION 1 FILED
Wednesday, January 26, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 3, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, June 20, 2021EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, March 10, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 9, 2021PUBLISHED FOR OPPOSITION
Wednesday, January 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 6, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 14, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 14, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 14, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 15, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 15, 2020NON-FINAL ACTION E-MAILED
Monday, June 15, 2020NON-FINAL ACTION WRITTEN
Friday, June 12, 2020ASSIGNED TO EXAMINER
Wednesday, March 25, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 25, 2020NEW APPLICATION ENTERED

Related Keywords


nasovax vaccines